With 30+ years of experience in biopharma, consulting, and operating leadership, I support life sciences teams in turning scientific and technical complexity into executable business and development strategy. My work focuses on bridging drug discovery, preclinical and clinical development, biologics/CMC, and corporate strategy so teams can make stronger decisions earlier. Public CV and expert profiles describe broad hands-on and advisory experience across the US, EU, Japan, and Australia, including roles in Big Pharma, biotech, and management consulting (Boston Consulting Group, Arthur D. Little, IBM), plus biopharma experience with Pharmacia and BASF Pharma. I also bring deep experience in business development, licensing/M&A, strategic planning, portfolio strategy, startup financing, and acting COO/CEO advisory support, which is especially valuable for emerging biotech companies navigating growth and risk.
BIOPHARMA STRATEGY & DEVELOPMENT ADVISOR
Per Ingemar Lindell, Sc.D., M.Sc.
Expert advisor in biopharma strategy, drug development, and biotech operations, with a rare mix of MIT biochemical engineering training, top-tier consulting background, and hands-on leadership across discovery, CMC, clinical development, and company building.
Biotechnology Management Consultant, MIT Sc.D.
LinkedIn profileAreas of expertise
-
Biopharma strategy & operations
-
Drug development, CMC
-
Biotech business development
-
Startup financing & due diligence
